CSIR-CFTRI’s Protein-Enriched Biscuits Reach COVID-19 Patients

CSIR-CFTRI’s Protein-Enriched Biscuits Reach COVID-19 Patients

  • Research Stash
  • News
  • 1.7K

The Mysuru-based CSIR-Central Food Technological Research Institute (CFTRI) has supplied high-protein biscuits to the COVID-19 patients undergoing treatment in the All India Institute of Medical Science (AIIMS), New Delhi.

CFTRI supplied 500 kg of high-protein biscuits and 500 kg of high-protein rusks to the Dietetics department of AIIMS to supply to the patients. The biscuits were supplied on request from the officials of the Institute.

The biscuits contain 14% of protein while usual biscuits contain around 8-9% protein.  “The enriched biscuits will provide the protein needed for recuperating patients”, says Dr. KSMS Raghavarao, Director, CSIR-CFTRI.

“It is also pertinent to mention here that the recipe formulation of the protein-enriched products is being done by the dedicated scientists of CSIR-CFTRI Mysuru and manufactured as per FSSAI regulations.,” says Dr. Parmeet Kaur, Chief Dietician, AIIMS, about the biscuits. COVID patients undergoing treatment in the hospital along with others will be receiving the biscuits as part of their routine diet.

The following ingredients go into the making of the biscuits: whole wheat flour (Atta), wheat flour (Maida), sugar, hydrogenated fat, soya flour, whey protein, soy protein, milk solids, glucose, INS 500II, and INS 503II agents, salt and flavors. A 100-g packet of biscuits clearly packs a punch with its energy quotient of 400 kcal and its nutritional value: carbohydrate (63.2 g), protein (14 g), fat (17.1 g) and minerals (1.2 g).

The biscuits are being manufactured in Noida, Uttar Pradesh, by Seven Seas Private Limited based on the formulation developed by CSIR-CFTRI. The logistic support to supply to the needy is being provided by the Indian Society of Agricultural Professionals, New Delhi. (ISW)

Kollegala Sharma

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

Rate

“It is also pertinent to mention here that the recipe formulation of the protein-enriched products is being done by the dedicated scientists of CSIR-CFTRI Mysuru and manufactured as per FSSAI regulations.,” says Dr. Parmeet Kaur, Chief Dietician, AIIMS, about the biscuits. COVID patients undergoing treatment in the hospital along with others will be receiving the biscuits as part of their routine diet.

The following ingredients go into the making of the biscuits: whole wheat flour (Atta), wheat flour (Maida), sugar, hydrogenated fat, soya flour, whey protein, soy protein, milk solids, glucose, INS 500II, and INS 503II agents, salt and flavors. A 100-g packet of biscuits clearly packs a punch with its energy quotient of 400 kcal and its nutritional value: carbohydrate (63.2 g), protein (14 g), fat (17.1 g) and minerals (1.2 g).

The biscuits are being manufactured in Noida, Uttar Pradesh, by Seven Seas Private Limited based on the formulation developed by CSIR-CFTRI. The logistic support to supply to the needy is being provided by the Indian Society of Agricultural Professionals, New Delhi. (ISW)

Kollegala Sharma

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

" }
New Web–Based Platform to Help Micro-Irrigation

New Web–Based Platform to Help Micro-Irrigation

A team of interdisciplinary scientists have come out with an online system that promises to substantially ease the process of planning and implementing micro-irrigation systems for agricultural fields

  • News
  • 2.3K
Read more
Extreme Rainfall Events in India Linked To Man-Made Emissions

Extreme Rainfall Events in India Linked To Man-Made Emissions

Here is more evidence why we need to worry about climate change. A new study says extreme rainfall events are on the rise in India and attributes the trend to man-made emissions, what scientists call anthropogenic warming.

  • News
  • 2.2K
Read more
Plant Virus-Like Particles as Vehicles for Therapeutic Antibodies

Plant Virus-Like Particles as Vehicles for Therapeutic Antibodies

Researchers at the Institute have developed a VLP of a plant virus called the Pepper vein banding virus to use as a possible vehicle to deliver antibodies into a cell. These VLPs can enter mammalian cells as well, despite being of plant origin.

  • News
  • 2.5K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit